Antigen-specific T cell response in infants after recombinant hepatitis B virus vaccination at birth: Evaluation of T helper lymphocyte diversity

Clinical Immunology

Volumn 107, Issue 2, 2003, Pages 122-128

  Avanzini, M A ^a   Belloni, C ^a   De Silvestri, A ^a   Castellazzi, A M ^b   Marconi, M ^b   Moretta, A ^a   Montagna, D ^b   Martinetti, M ^a   Cuccia, M ^b   Rondini, G ^a   Ciardelli, L ^a   Maccario, R ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Cytokines; Hepatitis B virus; T cell clones; T helper

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; RECOMBINANT HEPATITIS B VACCINE; VIRUS ANTIGEN;

ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ANTIGEN PURIFICATION; ANTIGEN SPECIFICITY; ARTICLE; BIRTH; CELL CLONE; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; HELPER CELL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN EXPERIMENT; INFANT; LYMPHOCYTE PROLIFERATION; NEWBORN; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; REVACCINATION; VACCINATION;

EID: 0038577132     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1521-6616(03)00047-0     Document Type: Article

References (28)

1. Craven D.E., Awdeh Z.L., Kunches L.M., Yunis E.J., Dienstag J.L., Werner B.G., et al. Nonresponsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic typings. Ann. Intern. Med. 105:1986;356-360.
2. Szmuness W., Stevens C.E., Harley F.I., Zang F.A., Oleszko W.R., William D.C., et al. Hepatitis B vaccine demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States . N. Engl. J. Med. 303:1980;833-841.
3. Dienstag J.L., Werner B.G., Polk B.F., Snydman D.R., Craven D.E., Platt R., et al. Hepatitis B vaccine in health care personnel safety, immunogenicity and indicators of efficacy . Ann. Intern. Med. 101:1984;34-40.
4. Kane M., Banatvala J., Da Villa G., Esteban R., Franco E., Goudeau A., et al. Are booster immunizations needed for lifelong hepatitis B immunity? Lancet. 355:2000;561-565.
5. Cheng K.F., Chang M.H., Lee C.Y., Huang L.M., Hsu H.Y., Lee P.I., et al. Response to supplementary vaccination with recombinant or plasma hepatitis B vaccine in healthy non-responding children. Vaccine. 12:1994;899-902.
6. Coursaget P., Yvonnet B., Gilks W.R., Wang C.C., Day N.E., Chiron J.P., et al. Scheduling of revaccination against hepatitis B virus. Lancet. 337:1991;1180-1183.
7. Belloni C., Tinelli C., Orsolini P., Pistorio A., Avanzini M.A., Moretta A., et al. Revaccination against hepatitis B virus of non responding infants immunised at birth. A parallel evaluation of rubella and tetanus vaccine. Vaccine. 16:1998;399-402.
8. McDermott A.B., Zuckerman J.N., Sabin C.A. Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination. Tissue Antigens. 50:1997;8-14.
9. Martinetti M., Cuccia M., Daielli C., Ambroselli F., Gatti C., Pizzochero C., et al. Anti-HBV neonatal immunization with recombinant vaccine. Part II. Molecular basis of the impaired allorectivity. Vaccine. 13:1995;555-560.
10. Salazar M., Deulofeut H., Granja C., Deulofeut R., Yunis D.E., Marcus-Bagley D., et al. Normal HBsAg presentation and T-cell defect in the immune response of nonresponders. Immunogenetics. 41:1995;366-374.
11. Chedid M.G., Deulofeut H., Yunis D.E., Lara-Marquez M.L., Salazar M., Deulofeut R., et al. Defect in Th1-like cells of nonresponders to hepatitis B vaccine. Human Immunol. 58:1997;42-51.
12. Degrassi A., Mariani E., Honorati M.C., Roda P., Miniero R., Capelli M., et al. Cellular response and anti-HBs synthesis in vitro after vaccination with yeast-derived recombinant hepatitis vaccine. Vaccine. 10:1992;617-622.
13. Leroux-Roels G., Van Hecke E., Michielsen W., Voet P., Hauser P., Petre J. Correlation between in vivo humoral and in vitro cellular immune responses following immunization with hepatitis B surface antigen (HBsAg) vaccines. Vaccine. 12:1994;812-818.
14. Larsen C.E., Xu J., Lee S., Dubey D., Uko G., Yunis E.J., Alper C.A. Complex cytokine responses to hepatitis B surface antigen and tetanus toxoid in responders, nonresponders and subjects naive to hepatitis B surface antigen. Vaccine. 18:2000;3021-3030.
15. Avanzini M.A., Belloni C., Soncini R., Ciardelli L., de Silvestri A., Tinelli C., et al. Increment of recombinant hepatitis B surface antigen-specific T-cell precursors after revaccination of slow responder children. Vaccine. 19:2001;2819-2824.
16. Romagnani S. Lymphokine production by human T cells in disease states. Annu. Rev. Immunol. 12:1994;227-257.
17. Abbas A.K., Murphy K.M., Sher A. Functional diversity of helper T lymphocytes. Nature. 383:1996;787-793.
18. Sallustro F., Mackay C.R., Lanzavecchia A. The role of chemokine receptors in primary, effector and memory immune response. Annu. Rev. Immunol. 18:2000;593-620.
19. Sallustro F., Lenig D., Forster R., Lipp M., Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 401:1999;708-712.
20. H2 and nonpolarized T cells . Nature Immunol. 1:2000;311-316.
21. Lanzavecchia A. Antigen specific interaction between T and B cells. Nature. 314:1985;537-539.
22. Abrignani S., Montagna D., Jeannet M., Wintsch J., Haigwood N.L., Shuster J.R., et al. Priming of CD4+ T cells specific for conserved regions of human immunodeficiency virus glycoprotein gp120 in human immunized with recombinant envelope protein. Proc. Natl. Acad. Sci. USA. 87:1990;6136-6140.
23. Valvassori M., Maccario R., Moretta A., Comoli P., Wack A., Locatelli F., et al. Restricted TCR repertoire and long-term persistence of donor-derived antigen-experienced CD4+ T cells in allogeneic bone marrow transplantation recipients. J. Immunol. 157:1996;5739-5747.
24. Honorati M.C., Dolzani P., Mariani E., Piacentini A., Lisignoli G., Ferrari C., et al. Epitope specificity of Th0/Th2 CD4+ T-lymphocytes clones induced by vaccination with rHBsAg vaccine. Gastroenterology. 112:1997;2017-2027.
25. Jung T., Schauer U., Rieger C., Wagner K., Einsle K., Neumann C., et al. Interleukin-4 and interleukin-5 are rarely co-expressed by human T cells. Eur. J. Immunol. 25:1995;2413-2416.
26. Caruso A., Licenziati S., Morelli D., Fiorentini S., Ricotta D., Malacarne F., et al. Segregation of type 1 cytokine production in human peripheral blood lymphocytes phenotypic differences between IFN-γ and IL-2-producing cells in the CD8+ T cell subset . Eur. J. Immunol. 28:1998;3630-3638.
27. Karukin A.Y., Hesse M.D., Tary-Lehmann M., Lehmann P.V. Single-cytokine-producing CD4 memory cells predominate in type 1 and type 2 immunity. J. Immunol. 164:2000;1862-1872.
28. Helms T., Boehm B.O., Asaad R.J., Trezza R.P., Lehmann P.V., Tary-Lehmann M. Direct visualization of cytokine-producing recall antigen-specific CD4 memory T cells in healthy individuals and HIV patients. J. Immunol. 164:2000;3723-3732.